Boiron S.A. (BOI.PA) Stock Analysis & Winston Score
Boiron is a French pharmaceutical company that makes homeopathic medicines — products made from highly diluted natural substances like plants and minerals. Its best-known product is Oscillococcinum, a remedy marketed for flu-like symptoms, sold in pharmacies across dozens of countries. Boiron is the world's largest manufacturer of homeopathic medicines. The company sells its products directly to pharmacies and healthcare distributors, earning revenue through product sales rather than subscriptions or licensing. It operates primarily in France and Western Europe, with a growing presence in the United States and other international markets. The main risk Boiron faces is scientific and regulatory pressure — health authorities in several countries have questioned whether homeopathic products work better than placebos, and some governments have reduced or eliminated reimbursement for these medicines, which could shrink demand over time.
Winston Score: 65/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (17/30)
- Growth: Mixed (9/20)
- Cash Flow: Strong (8/10)
- Stability: Exceptional (10/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)

